semaglutide
PulseAugur coverage of semaglutide — every cluster mentioning semaglutide across labs, papers, and developer communities, ranked by signal.
- 2026-05-26 research_milestone New research indicates semaglutide may alleviate osteoarthritis-related inflammation and tissue damage, independent of weight loss. source
3 day(s) with sentiment data
-
Medicare launches $50/month GLP-1 weight loss drug program
The Trump administration has launched a temporary Medicare Bridge program to provide some beneficiaries with access to popular weight loss medications like tirzepatide and semaglutide for a flat $50 monthly co-payment. …
-
GLP-1 weight-loss drugs drive major climate impact by cutting food demand
The widespread adoption of GLP-1 medications for weight loss is having a significant, albeit unintended, impact on the climate by reducing demand for carbon-intensive foods. As more Americans use drugs like semaglutide …
-
Novo Nordisk CEO eyes longevity and aesthetics beyond weight loss drugs
Novo Nordisk's CEO, Mike Doustdar, is exploring new therapeutic areas beyond weight loss and diabetes, including longevity and aesthetic medicine. The company is investigating semaglutide's potential to protect vital or…
-
GLP-1 drugs show anti-inflammatory benefits beyond weight loss
GLP-1 medications like Ozempic and Wegovy, known for weight loss, are showing promise in treating inflammation and tissue damage, particularly in osteoarthritis. A study in Cell Metabolism found semaglutide reduced infl…
-
US considers AI oversight, China drug firm seeks global partners
Guoyao Taiji's investigational drug semaglutide was showcased at the Canton Fair, initiating global investment outreach. The company has established API and formulation production facilities compliant with Chinese and U…